Explore

Rapid ReadRapid Read
Review Highlights Gaps in Premenopausal Breast Cancer Treatment Strategies, Urging Individualized Care

Review Highlights Gaps in Premenopausal Breast Cancer Treatment Strategies, Urging Individualized Care

A comprehensive review published in Annals of Oncology, authored by L. Licata and colleagues, identifies significant gaps in the management of premenopausal women with HR-positive/HER2-negative early breast cancer. The review, titled 'Navigating Uncertainties and Evidence Gaps in Adjuvant Therapy for Premenopausal Women With HR-Positive/HER2-Negative Breast Cancer,' synthesizes data from multiple studies, including SOFT, TEXT, ASTRRA, TAILORx, RxPONDER, MINDACT, and OPTIMA. It emphasizes that treatment strategies for premenopausal breast cancer cannot simply mirror those for older women due to differences in tumor biology, ovarian function, chemotherapy-induced menopause, treatment toxicity, and reproductive priorities. A key limitation noted in trials like TAILORx and RxPONDER is that only about 13% of premenopausal patients in endocrine therapy control groups received ovarian function suppression (OFS), suggesting that the observed chemotherapy benefits might partly stem from an endocrine effect rather t...
Rapid ReadRapid Read
BYU Researchers Develop MOTO-CAR Immunotherapy for Difficult-to-Cure Cancers

BYU Researchers Develop MOTO-CAR Immunotherapy for Difficult-to-Cure Cancers

Researchers at Brigham Young University (BYU) have developed a new immunotechnology called MOTO-CAR, which genetically engineers macrophages to recognize and attack cancer cells. This technology aims to convert a patient's own immune system into a cancer-fighting mechanism. According to lead researcher and BYU professor of microbiology and molecular biology Kim O'Neill, this method could lead to new treatments for cancers that are currently difficult to cure, such as glioblastoma, triple-negative breast cancer, and pancreatic cancer. Preclinical trials have shown promising results; in one in vitro study, a 90% reduction in aggressive lung cancer cells was observed within 24 hours. Another study in mice demonstrated a reduction in tumor sizes by up to 46% with a single treatment regimen. The process involves identifying cancer biomarkers from a tumor biopsy, selecting a pre-engineered MOTO-CAR therapeutic, and administering it via infusion. The research is currently in the preclinical stage, and further fun...
Rapid ReadRapid Read
GeneSPOT Computational Framework Introduced to Map Spatial Gene Relationships and Dynamics in Tissues

GeneSPOT Computational Framework Introduced to Map Spatial Gene Relationships and Dynamics in Tissues

Researchers have developed Gene SPatial Optimal Transport, or GeneSPOT, a new computational framework designed to characterize the spatial relationships among genes and quantify their reorganization across various biological conditions and over time. Published in Nature Methods, this gene-centric analytical framework complements existing cell-centric methods by mapping how the relational spatial organization of molecular features changes within tissues. While current spatial omics technologies primarily focus on identifying cellular states and differentially expressed molecular features, GeneSPOT extends this by evaluating spatial arrangements beyond individual cellular states. The framework has successfully resolved tissue structures in diverse applications, including validation analyses in the mouse brain, where it captured biologically meaningful spatial gene programs and identified organized molecular patterns within complex tissue architecture.
TrendlineTrendline
Immunome Reports Strong Q3 2026 Financial Results and Advances Oncology Pipeline with New Clinical Trials

Immunome Reports Strong Q3 2026 Financial Results and Advances Oncology Pipeline with New Clinical Trials

Immunome Reports Strong Q3 2026 Financial Results and Advances Oncology Pipeline with New Clinical Trials
TrendlineTrendline
Macrogen Launches Next-Generation Spatial Transcriptome Analysis Service in Asia

Macrogen Launches Next-Generation Spatial Transcriptome Analysis Service in Asia

Macrogen Launches Next-Generation Spatial Transcriptome Analysis Service in Asia
Rapid ReadRapid Read
Exercise Programs Show Psychological Benefits for Cancer Patients, Addressing Mental Health as National Priority

Exercise Programs Show Psychological Benefits for Cancer Patients, Addressing Mental Health as National Priority

Adapted physical activity (APA) programs are increasingly recognized for their psychological benefits in cancer patients, extending beyond the well-established reduction of cancer-related fatigue. Experts Marion Barrault-Couchouron, psychologist and psychotherapist at Bergonié Cancer Institute, and Charlène Goetgheluck Villaron, PhD, associate professor at Management Sport Cancer Laboratory, highlighted these benefits at the 17th National Congress on Supportive Care in Oncology. They emphasized the need to prioritize mental health in oncology care, noting that physical activity can serve as a crucial first step for patients to set physical goals. Research indicates that APA can reduce anxiety in women with breast cancer by improving body image, with some benefit for depression, particularly in patients living alone, with intermediate education, or moderate baseline depression. Even gentle exercise, previously considered too low-intensity, has shown physiological benefits, especially for anxiety. Programs l...
TrendlineTrendline
Olema Oncology Reports Third Quarter 2026 Financial Results and Advances Breast Cancer Therapies

Olema Oncology Reports Third Quarter 2026 Financial Results and Advances Breast Cancer Therapies

Olema Oncology Reports Third Quarter 2026 Financial Results and Advances Breast Cancer Therapies
Rapid ReadRapid Read
Genome Editing Technology Advances Precision in Medicine and Agriculture

Genome Editing Technology Advances Precision in Medicine and Agriculture

Recent advancements in genome editing technology are significantly improving the precision of genetic modifications across various fields, including medicine, agriculture, and cosmetics. Researchers are making strides in enhancing the accuracy of genome correction, particularly in introducing defined DNA sequences at chosen genomic sites. Studies highlight that the design of donor molecules is crucial for biasing repair towards intended outcomes. For instance, single-stranded DNA donor repair templates used with CRISPR/Cas9 have shown high frequency of targeted insertion in potato protoplasts, while CRISPR-Cas12a combined with homology-directed repair has proven effective for targeted insertion in maize. In human cells, a circular donor DNA paired with a dedicated cleaver is being explored to improve the precision of genome correction. The field is also seeing the evolution of tools from zinc-finger nucleases and TALENs to CRISPR-Cas9, base, and prime editors, with applications in monogenic diseases like s...
Rapid ReadRapid Read
Mount Sinai Health System Seeks Bioinformatician III for AI Human Health Research

Mount Sinai Health System Seeks Bioinformatician III for AI Human Health Research

The Mount Sinai Health System's Artificial Intelligence and Human Health Department is actively seeking a Bioinformatician III to join its expanding genomics and precision medicine research program. This role is designed for a highly motivated genetic epidemiologist or statistical geneticist who will be instrumental in leading and supporting analyses of extensive genomic, proteomic, multi-omics, and longitudinal clinical datasets. The successful candidate will apply advanced statistical genetics, bioinformatics, machine learning, and AI methodologies to uncover the biological underpinnings of complex and rare diseases. This position offers a unique opportunity to spearhead independent research projects, contribute to high-impact publications and grant applications, and collaborate within a multidisciplinary team at the forefront of human genetics and precision medicine. The role requires a minimum of six years of experience and proficiency in various computational tools and environments, including R, Pytho...
TrendlineTrendline
Precision for Medicine Seeks Resource Manager to Optimize Oncology Development Pathway

Precision for Medicine Seeks Resource Manager to Optimize Oncology Development Pathway

Precision for Medicine Seeks Resource Manager to Optimize Oncology Development Pathway
Rapid ReadRapid Read
New Research Clarifies Genetic Risk in Pattern Dystrophy Using Protein Structure and AI

New Research Clarifies Genetic Risk in Pattern Dystrophy Using Protein Structure and AI

A recent medRxiv preprint, titled “Advancing genetic pathogenicity prediction with three-dimensional proteoform-phenotype analysis,” introduces a novel framework to better understand genetic risk in inherited retinal diseases, specifically pattern dystrophy. This research combines computer-generated protein structure models with clinical genetic data and expert review to identify which PRPH2 gene variants are likely harmful. The study focused on missense variants, which are DNA changes that substitute one protein building block for another, and evaluated 46 pathogenic PRPH2 missense variants against a broader pool of variants of uncertain significance (VUS). By using artificial intelligence-generated models, researchers examined where variants occurred within the protein and how they might affect its physical and biological properties. This 'human-in-the-loop' approach ensures that AI-identified patterns are biologically meaningful and consistent with real patient presentations.
Rapid ReadRapid Read
mRNA COVID-19 Vaccines Show Unexpected Benefits in Cancer Treatment and Prevention

mRNA COVID-19 Vaccines Show Unexpected Benefits in Cancer Treatment and Prevention

Recent scientific findings indicate that mRNA COVID-19 vaccines may offer unexpected benefits beyond their primary role in preventing viral infection. Researchers have discovered that receiving an mRNA COVID shot can enhance the effectiveness of certain cancer therapies, leading to improved three-year survival rates for patients. This breakthrough has spurred pharmaceutical companies to explore and develop personalized cancer vaccines utilizing mRNA technology. These new vaccines aim to target individual patients' tumors, representing a significant advancement in oncology. This development highlights how scientific innovations, even when focused on one area, can yield unforeseen positive outcomes in other critical public health domains. The initial success in improving cancer therapy efficacy suggests a broader potential for mRNA technology in medical treatments.